The Cooper Companies Inc (COO) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Jul 31 2026 to Jul 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
The Cooper Companies Inc   (NASDAQ: COO)

The Cooper Companies Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for The Cooper Companies Inc in the third quarter 2026?
The Cooper Companies Inc achieved a return on average equity (ROE) of 6.9 % in its third quarter 2026, which is below The Cooper Companies Inc 's average return on equity, which stands at 11.6%.

ROE has advanced compared to 2.85% in the second quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 48 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 1957 to 2145.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jul 31 2026)
III. Quarter		 (Apr 30 2026)
II. Quarter		 (Jan 31 2026)
I. Quarter		 (Oct 31 2025)
IV. Quarter		 (Jul 31 2025)
III. Quarter
Y / Y Equity Change -0.29 % -0.59 % 1.92 % 1.92 % -
Y / Y Net Income Change 340.28 % - 25.41 % -28 % -6.11 %
Net Income (TTM) in Millions 570 236 401 375 408
Return On Equity (TTM) 6.9 % 2.85 % 4.85 % 4.55 % 4.97 %
COO's Total Ranking # 2145 # 1957 # 1548 # 1791 # 1651
Equity (TTM) in Millions 8,328 8,239 8,239 8,239 8,353
Seq. Equity Change 1.08 % 0 % 0 % -1.36 % 0.78 %
Seq. Net Income Change - - 54.61 % -13.94 % 12.09 %

Back to COO Management Effectiveness >> COO's 5 Years Annual ROE >> Compare COO ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 49
Sector # 160
Overall # 2145

Return On Equity Statistics
High Average Low
59.83 %
11.6 %
2.85 %
(Jan 31 2021)   (Apr 30 2026)





COO Annual Return On Equity (Oct 31 2025)
2025		 (Oct 31 2024)
2024		 (Oct 31 2023)
2023		 (Oct 31 2022)
2022		 (Oct 31 2021)
2021
Total Equity in Millions 8,239 8,084 7,551 7,175 6,942
Y / Y Equity Change 1.92 % 7.05 % 5.24 % 3.35 % 81.5 %
Net Income in Millions 375 392 294 386 2,945
Y / Y Net Income Change -4.44 % 33.34 % -23.74 % -86.9 % 1135.19 %
Return On Equity 4.55 % 4.85 % 3.9 % 5.38 % 42.42 %

Back to COO Management Effectiveness >> COO's 5 Years Annual ROE >> Compare COO ROE to its Competitors




Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 4.55 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
COO's' Return on Equity at Yahoo Finance
COO's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for COO's Competitors
Subscribers only: Roe for The Cooper Companies Inc 's Suppliers
Subscribers only: Return On Equity for COO's Customers




Companies with similar Return On Equity at Jul 31 2026, within Healthcare Sector ROE
Brightspring Health Services Inc   18.93 %
Sbc Medical Group Holdings Incorporated  18.69 %
West Pharmaceutical Services Inc   18.51 %
Intuitive Surgical Inc   17.82 %
Standard Biotools Inc   17.64 %
Inspire Medical Systems inc   17.62 %
Medinotec Inc   17.47 %
Lemaitre Vascular Inc   16.93 %
Ufp Technologies Inc   16.72 %
Ensign Group Inc  16.53 %
Stryker Corp  16.36 %
Nephros Inc   16.20 %
Spero Therapeutics Inc   16.17 %
Progyny Inc   15.98 %
Collegium Pharmaceutical Inc   15.96 %
Alpha Pro Tech Ltd   15.43 %
Livanova Plc  15.41 %
Biolife Solutions Inc   15.28 %
Lifevantage Corp  15.06 %
Quest Diagnostics Inc  14.85 %
Infusystem Holdings Inc  14.81 %
Boston Scientific Corporation  14.77 %
Strata Critical Medical Inc   14.27 %
Beone Medicines Ltd   14.24 %
Royalty Pharma Plc  13.82 %
Regeneron Pharmaceuticals Inc   13.81 %
National Healthcare Corp  13.11 %
Kewaunee Scientific Corporation  12.61 %
Protagonist Therapeutics inc   11.80 %
Entrada Therapeutics Inc   11.77 %

Date modified: 2026-09-11T09:38:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.